Healthcare

UK considers continuous monitoring of healthcare AI

The UK is moving toward continuous monitoring of healthcare AI as regulators reconsider oversight of rapidly evolving systems.

The United Kingdom is moving toward continuous monitoring of artificial intelligence used in healthcare as part of a broader regulatory overhaul. The reported policy direction reflects concern about technologies that can change rapidly after deployment.

Continuous monitoring differs from relying only on an initial approval or pre-deployment assessment. It would require healthcare AI systems to be observed over time as their performance, data, and operating environments evolve.

The initiative is linked to the UK government’s effort to update regulation for rapidly developing AI. Healthcare is treated as a particularly important area because errors or unexpected changes can affect diagnosis, treatment, and patient safety.

The development matters because monitoring requirements could influence how hospitals procure, validate, and manage AI tools. It also signals that regulators are considering lifecycle oversight rather than treating approval as the end of governance.

Original source: Fox News

Related RAQI solutions

In-depth analysis on RAQI Insight

Work with RAQI